Provision and delivery of survivorship care for adult patients with haematological malignancies: A scoping review protocol.

Autor: Baldwin ZV; Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, United Kingdom.; Institute for Clinical and Applied Health Research, University of Hull, Hull, United Kingdom., Busby S; Institute for Clinical and Applied Health Research, University of Hull, Hull, United Kingdom.; Academy of Primary Care, Hull York Medical School, University of Hull, Hull, United Kingdom., Allsup D; Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, United Kingdom.; Hull University Teaching Hospital Trust, Hull, United Kingdom., Cohen J; Institute for Clinical and Applied Health Research, University of Hull, Hull, United Kingdom.; Hull Health Trials Unit, Hull York Medical School, University of Hull, Hull, United Kingdom., Bamidele O; Institute for Clinical and Applied Health Research, University of Hull, Hull, United Kingdom.; Cancer Awareness, Screening and Diagnostic Pathways Research Group, Hull York Medical School, University of Hull, Hull, United Kingdom.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2023 Mar 02; Vol. 18 (3), pp. e0282458. Date of Electronic Publication: 2023 Mar 02 (Print Publication: 2023).
DOI: 10.1371/journal.pone.0282458
Abstrakt: Introduction: Haematological malignancies are a heterogenous group of blood and lymphatic cancers. Survivorship care is a similarly diverse term concerning patients' health and wellbeing from diagnosis to end of life. Survivorship care for patients with haematological malignancies has traditionally been consultant-led and secondary care-based, although shifts away from this model have been occurring, largely via nurse-led clinics and interventions with some remote monitoring. However, there remains a lack of evidence regarding which model is most appropriate. Although previous reviews exist, patient populations, methodologies, and conclusions are varied, and further high-quality research and evaluation has been recommended.
Aims: The aim of the scoping review this protocol describes is to summarise current evidence on the provision and delivery of survivorship care for adult patients diagnosed with a haematological malignancy, and to identify existing gaps to inform future research.
Methodology: A scoping review will be carried out utilising Arksey and O'Malley's guidelines as its methodological framework. Studies published in the English language from December 2007 to the present will be searched on bibliographic databases, including Medline, CINAHL, PsycInfo, Web of Science, and Scopus. Papers' titles, abstracts, and full text will predominantly be screened by one reviewer with a second reviewer blind screening a proportion. Data will be extracted using a customised table developed in collaboration with the review team, and presented in tabular and narrative format, arranged thematically. Studies included will contain data regarding adult (25+) patients diagnosed with any haematological malignancy in combination with aspects related to survivorship care. The survivorship care elements could be delivered by any provider within any setting, but should be delivered pre- or post-treatment, or to patients on a watchful waiting pathway.
Registration: The scoping review protocol has been registered on the Open Science Framework (OSF) repository Registries (https://osf.io/rtfvq; DOI: 10.17605/OSF.IO/RTFVQ).
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2023 Baldwin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje